Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Novo Nordisk Announces Significant Price Drops for Popular GLP-1 Medications Mike Hollan Key Takeaways Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs
Shiraishi, D., Fujiwara, Y., Komohara, Y., Mizuta, H
Some doctors may prescribe Ozempic off-label (for a different purpose than its FDA approval) for weight loss
But GLP-1s Carry Serious Risks for People With Type 1 Diabetes Despite the strong results, theres a reason why experts are very cautious about recommending the use of semaglutide and tirzepatide for people with type 1 diabetes
PloS One (2013) 8(3):e58784
US$ 27.90
US$ 24.41
US$ 20.93
US$ 28.10
US$ 29.20
US$ 27.17
US$ 23.27
